Edition:
United States

Gemphire Therapeutics Inc (GEMP.OQ)

GEMP.OQ on NASDAQ Stock Exchange Global Market

1.01USD
18 Jan 2019
Change (% chg)

$0.01 (+1.00%)
Prev Close
$1.00
Open
$1.05
Day's High
$1.05
Day's Low
$0.96
Volume
20,090
Avg. Vol
38,919
52-wk High
$11.41
52-wk Low
$0.57

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.00 -0.426
Jun '18 0.00 -0.469
Mar '18 0.00 -0.581
FY 2017 Dec '17 0.00 -0.634
Sep '17 0.00 -0.816
Jun '17 0.00 -0.990
Mar '17 0.00 -0.787
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-19 2 0.00 0.00 0.00 0.00
Quarter Ending Jun-19 2 0.00 0.00 0.00 0.00
Year Ending Dec-19 3 0.00 0.00 0.00 2.93
Earnings (per share)
Quarter Ending Mar-19 1 -0.42 -0.42 -0.42 --
Quarter Ending Jun-19 1 -0.35 -0.35 -0.35 --
Year Ending Dec-19 4 -2.62 -1.59 -3.27 -3.32
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 95.96 30.88
P/E High - Last 5 Yrs. -- 287.89 46.69
P/E Low - Last 5 Yrs. -- 90.15 25.78
Beta -- 0.66 0.95
Price to Sales (TTM) -- 242.95 21.76
Price to Book (MRQ) 1.60 18.87 4.53
Price to Tangible Book (MRQ) 1.60 22.13 11.76
Price to Cash Flow (TTM) -- 54.67 22.24
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.39 1.60
Dividend Yield - 5 Year Avg -- 0.20 1.42
Dividend 5 Year Growth Rate -- 3.31 -8.76
Payout Ratio(TTM) -- 6.79 44.03

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 156.34 6.54
Sales (TTM) vs TTM 1 Yr. Ago -- 61.53 5.26
Sales - 5 Yr. Growth Rate -- 24.06 7.59
EPS (MRQ) vs Qtr. 1 Yr. Ago 47.77 196.06 22.50
EPS (TTM) vs TTM 1 Yr. Ago 27.22 -- --
EPS - 5 Yr. Growth Rate -- 23.46 7.64
Capital Spending - 5 Yr. Growth Rate -- 37.07 8.38

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 3.57 2.63
Current Ratio (MRQ) 3.26 6.87 3.68
LT Debt to Equity (MRQ) 58.95 16.70 9.53
Total Debt to Equity (MRQ) 92.87 21.89 13.39
Interest Coverage (TTM) -359.41 -289.65 33.85

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 31.33 50.91
Gross Margin - 5 Yr. Avg. -- 47.59 52.22
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -141.70 16.27
Operating Margin (TTM) -- -1,638.83 -15.11
Operating Margin - 5 Yr. Avg. -- -155.53 11.89
Pre-Tax Margin (TTM) -- -1,574.14 -13.67
Pre-Tax Margin - 5 Yr. Avg. -- -157.11 12.22
Net Profit Margin (TTM) -- -1,572.92 -17.11
Net Profit Margin - 5 Yr. Avg. -- -158.05 8.44
Effective Tax Rate (TTM) -- 15.93 21.73
Effective Tax Rate - 5 Yr. Avg. -- 19.64 24.41

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 28,103,806 878,349,382
Net Income/Employee (TTM) -1,484,833 -3,710,889 102,474,711
Receivable Turnover (TTM) -- 9.19 5.49
Inventory Turnover (TTM) -- 2.64 3.99
Asset Turnover (TTM) 0.00 0.46 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -104.65 0.35 11.06
Return on Assets - 5 Yr. Avg. -- 2.90 11.85
Return on Investment (TTM) -143.81 0.60 13.80
Return on Investment - 5 Yr. Avg. -- 2.87 15.17
Return on Equity (TTM) -256.97 -2.18 15.29
Return on Equity - 5 Yr. Avg. -- -0.88 16.29
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -25.45 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Gemphire Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 28.06%
# of Holders: 34
Total Shares Held: 4,002,512
3 Mo. Net Change: -504,594
# New Positions: 11
# Closed Positions: 21
# Increased Positions: 16
# Reduced Positions: 26
# Net Buyers: -10
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.